Crizotinib in the management of advanced-stage non-small-cell lung cancer

Future Oncology
Herbert H LoongTony S K Mok

Abstract

ABSTRACT  Rearrangement of ALK gene has been identified as exerting a potent transforming effect as driver oncogene in patients with non-small-cell lung cancer (NSCLC). Crizotinib is a small-molecule oral inhibitor of ALK, c-Met/HGF receptor and ROS1 receptor kinases. Its efficacy in ALK-rearranged NSCLC has been established. Crizotinib's effect on ROS1 receptor kinases and c-Met with relevance to NSCLC is also actively being explored. Resistance mechanisms such as secondary gatekeeper mutations in ALK gene and activation of other oncogenes have been identified to confer acquired resistance to crizotinib. This article reviews the pharmacological properties of crizotinib, preclinical and clinical results that led to its approval in ALK-positive NSCLC and current directions of clinical research in overcoming crizotinib resistance.

References

Jul 25, 2006·Nature Reviews. Cancer·Carla Boccaccio, Paolo M Comoglio
Apr 23, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kengo TakeuchiHiroyuki Mano
Aug 21, 2009·The New England Journal of Medicine·Tony S MokMasahiro Fukuoka
Jun 25, 2010·The New England Journal of Medicine·Makoto MaemondoUNKNOWN North-East Japan Study Group
Jun 30, 2010·Clinical Oncology : a Journal of the Royal College of Radiologists·L T Tan
Oct 14, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lecia V SequistRonald Natale
Oct 29, 2010·The New England Journal of Medicine·Eunice L KwakA John Iafrate
Nov 26, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Sai-Hong Ignatius OuA John Iafrate
Apr 20, 2011·Proceedings of the National Academy of Sciences of the United States of America·Ryohei KatayamaAlice T Shaw
May 31, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Sai-Hong Ignatius OuA John Iafrate
Nov 16, 2011·Therapeutic Advances in Medical Oncology·Yung-Jue Bang
Nov 18, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Sai-Hong Ignatius OuJonathan A Stiber
Jan 5, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kristin BergethonA John Iafrate
Jan 12, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert C DoebeleD Ross Camidge
Jan 27, 2012·Science Translational Medicine·Ryohei KatayamaJeffrey A Engelman
Jan 31, 2012·The Lancet Oncology·Rafael RosellUNKNOWN Spanish Lung Cancer Group in collaboration with Groupe Français de Pneumo-Cancérologie and Associazione Italiana Oncologia T
Apr 17, 2012·Expert Review of Anticancer Therapy·Sai-Hong Ignatius OuRoss A Soo
May 2, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Leena Gandhi, Pasi A Jänne
May 19, 2012·Expert Opinion on Pharmacotherapy·Patrick M Forde, Charles M Rudin
Aug 25, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kurtis D DaviesRobert C Doebele
Jan 25, 2013·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Soyeon KimDae Seog Heo
Mar 15, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J FerlayF Bray
Mar 22, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·W CaiG Schmid-Bindert
Jun 4, 2013·The New England Journal of Medicine·Alice T ShawPasi A Jänne
Jul 3, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lecia V SequistMartin Schuler
Feb 6, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Douglas D FangChi-Chung Chan
Mar 29, 2014·The New England Journal of Medicine·Alice T ShawJeffrey A Engelman
Mar 29, 2014·Cancer Discovery·Luc FribouletJeffrey A Engelman
May 27, 2014·American Society of Clinical Oncology Educational Book·David E GerberDaniel B Costa
Jun 27, 2014·Japanese Journal of Clinical Oncology·Yuki SatoKeisuke Tomii
Sep 30, 2014·The New England Journal of Medicine·Alice T ShawA John Iafrate

❮ Previous
Next ❯

Citations

Aug 24, 2016·Expert Review of Molecular Diagnostics·Frederic G Barr
Dec 12, 2018·Journal of Comparative Effectiveness Research·Daphne I LingNick Bansback
Nov 22, 2019·Briefings in Bioinformatics·Hongcheng YaoMulin Jun Li
Apr 12, 2017·European Journal of Nuclear Medicine and Molecular Imaging·S LheureuxF M Mottaghy

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT02201992
NCT00585195
NCT00932451
NCT00932893
NCT01154140

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
Alice T ShawJeffrey A Engelman
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
Soyeon KimDae Seog Heo
Lung Cancer : Journal of the International Association for the Study of Lung Cancer
Xiaolong QiCaicun Zhou
© 2022 Meta ULC. All rights reserved